✦ LIBER ✦

ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia

✍ Scribed by Loukas Argyriou; Robert Pfitzmann; Lars-Erik Wehner; Stefan Twelkemeyer; Peter Neuhaus; Karim Nayernia; Wolfgang Engel

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 81 KB
Volume: 11
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20544

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Liver transplantation for cardiac failur

Liver transplantation for cardiac failure in patients with hereditary hemorrhagic telangiectasia

✍ Thierry Thevenot; Claire Vanlemmens; Vincent Di Martino; Marie-Claude Becker; Pi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Liver involvement in hereditary hemorrhagic telangiectasia may lead to high-output cardiac failure. Few data have been reported on orthotopic liver transplantation (OLT) for these patients. In this paper, we describe two patients treated by OLT as a salvage procedure for cardiac failure, and we revi

Bevacizumab reverses need for liver tran

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia

✍ Andrew Mitchell; Leon A. Adams; Gerry MacQuillan; Jon Tibballs; Rohan vanden Dri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by mucocutaneous and visceral telangiectasia. Hepatic involvement with vascular malformations may lead to portal hypertension, biliary ischemia, and high-output cardiac failure. Liver transplantation is indica

Mutation study of Spanish patients with

Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1

✍ Africa Fernandez-L; Francisco Sanz-Rodriguez; Roberto Zarrabeitia; Alfonso Perez 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant and age-dependent vascular disorder originated by mutations in Endoglin (ENG) or activin receptor-like kinase-1 (ALK1, ACVRL1) genes. The first large series HHT analysis in Spanish population has identified mutations in 17 unrelate

Reply: Bevacizumab reverses need for liv

Reply: Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia

✍ Leon A. Adams; Andrew Mitchell; Gerry MacQuillan; Jonathon Tibballs; Rohan vande 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

unclear, and further experience in a clinical trial setting is required to clarify this. Lastly, it is exciting to ponder that vascular endothelial growth factor antagonists may have a role in reducing symptoms in the substantial number of HHT patients who are symptomatic but do not require liver tr

Hepatic manifestation is associated with

Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: Identification of five novel ALK1 and one novel ENG mutations

✍ Heidi K.A. Kuehl; Martin Caselitz; Sandra Hasenkamp; Siegfried Wagner; El-Harith 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Hereditary hemorrhagic telangiectasia (HHT), or Osler-Rendu-Weber syndrome, is a heterogeneous inherited disorder characterized by multi-systemic vascular dysplasia and wide variation in its phenotypic expression. Hepatic manifestation is seen in about 8 to 30 % of the patients. The molecular basis

BMPR2 mutation in a patient with pulmona

BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia

✍ Christina M. Rigelsky; Constance Jennings; Rainer Lehtonen; Omar A. Minai; Chari 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

## Abstract Pulmonary arterial hypertension (PAH) and hereditary hemorrhagic telangiectasia (HHT) are distinct clinical entities caused by germline mutations in genes encoding members of the TGFβ/BMP superfamily: __BMPR2__ in PAH and __ACVRL1__, __ENG__, or __SMAD4__ in HHT. When PAH and HHT occasi